CBA Florida Inc. (fka CBAI)

[MrLong]

!!!Major!!! LifeBank Inc.(Celgene), ViaCord, Cord Blood Registry and Cryocell all collaborate on Placenta & Cord Blood Storage Patent. They are one!

That is what we saw in the CBAI new kit video!!!!!

They mix donor Placenta with Umbilical. Privates Viacord, Cryocell, CBR, Lifebank: "4.1. METHODS OF ISOLATING AND CULTURING PLACENTA 4. 1. 1. Pretreatment of Placenta According to the methods of the invention, a human placenta is recovered shortly after its expulsion after birth and, in certain embodiments, the cord blood in the placenta is recovered. In certain embodiments, the placenta is subjected to a conventional cord blood recovery process. Such cord blood recovery may be obtained commercially, e. g., LifeBank Inc., Cedar Knolls, N. J. , ViaCord, Cord Blood Registry and Cryocell. The cord blood can be drained shortly after expulsion of the placenta.


"Donor" as used herein means an adult, child, infant, or, preferably, a placenta. In another, preferred, embodiment, the method comprises administering to said individual embryonic-like stem cells that are collected from a plurality of donors and pooled. In a specific embodiment, said embryonic-like stem cells are stem cells taken from a plurality of donors. When collected form multiple donors, the dosage units, where a "dosage unit" is a collection from a single donor, may be pooled prior to administration, may be administered sequentially, or may be administered alternatively. In another embodiment of the method, said embryonic-like stem cells are mixed with, or"spiked"into umbilical cord blood, and the mixture administered to an individual. In more specific embodiments of the method, the ratio of embryonic-like stem cells to cord blood may be at least 20: 80,30 : 70,40 : 60,50 : 50,60 : 40,70 : 30 or 80: 20, by number of total nucleated cells.

4.8 KITS The invention also provides a pharmaceutical pack or kit comprising one or more containers filled with one or more of the ingredients of the pharmaceutical compositions of the invention. Optionally associated with such container (s) can be: an apparatus for cell culture, one or more containers filled with a cell culture medium or one or more components of a cell culture medium, an apparatus for use in delivery of the compositions of the invention, e. g., an apparatus for the intravenous injection of the compositions of the invention, and/or a notice in the form prescribed by a governmental agency regulating the manufacture, use or sale of pharmaceuticals or biological products, which notice reflects approval by the agency of manufacture, use or sale for human administration. In a specific embodiment, the kit comprises one or more containers filled with embryonic-like stem cells of the invention and one or more different containers filled with stem cells, e. g. , umbilical cord blood, as disclosed above.

In one embodiment, the kit comprises a mixture of stem cells, e. g. , cord blood cells, supplemented with embryonic-like stem cells contained within one bag or container. In another embodiment, the kit comprises a population of cord blood cells and a population of embryonic-like stem cells that are contained within two separate bags or containers. In certain embodiments, the kit comprises a"two bag"composition wherein the bag containing the cord blood cells and the bag containing the embryonic-like stem cells is mixed prior to, or at the time of, administration to a patient in need thereof. In other embodiments, the kit comprises a population of cord blood cells and a population of embryonic-like stem cells that are contained within two separate bags or containers and that are administered separately (e. g. , simultaneously or sequentially) to a patient, wherein the mixing of the two cell populations occurs i71 vivo.
http://www.wipo.int/pctdb/fr/wo.jsp?

CBAI ROLLS WITH THE MAJORS!!!!!!!!!!!!!!!!!!!!! THEY MUST BE ONE!